Equitable access to diagnosis and treatment for individuals with rare and less common cancers, including neuroendocrine cancer, with particular reference to:

a. barriers to screening and diagnosis, including the impact of factors such as:
i. geographic location,
ii. cost,
iii. cultural and language barriers,
iv. type of cancer, and
v. availability of treating practitioners;

b. barriers to accessing appropriate treatment;

c. the adequacy of support services after diagnosis;

d. the adequacy of Commonwealth funding for research into rare, less common and neuroendocrine cancer; and

e. any other related matters.